Privi Speciality Chemicals Limited has submitted its quarterly compliance certificate under SEBI regulations for the fourth quarter of fiscal year 2026. The submission demonstrates the company's adherence to regulatory requirements for securities dematerialisation processes.

Regulatory Compliance Submission

The company submitted the certificate under Regulation 74(5) of SEBI (Depository & Participants) Regulations, 2018 for the quarter ended March 31, 2026. Company Secretary Ashwini Saumil Shah signed and submitted the document on April 06, 2026, to both BSE Limited and National Stock Exchange of India Ltd.

Certificate Confirmation Details

MUFG Intime India Private Limited, formerly known as Link Intime India Private Limited, serves as the Registrar and Share Transfer Agent for Privi Speciality Chemicals. The certificate confirms several key compliance aspects for the quarter:

• Securities received from depository participants for dematerialisation were confirmed (accepted/rejected) to depositories
• Securities comprised in certificates have been listed on stock exchanges where earlier issued securities are listed
• Security certificates received for dematerialisation were confirmed/rejected within prescribed timelines
• Security certificates were mutilated and cancelled after due verification by depository participants
• Names of depositories were substituted in the register of members as registered owners

Corporate Information

The company operates from its registered office at Privi House, A-71, TTC, Thane Belapur Road, Near Kopar Khairane Railway Station, Navi Mumbai. Privi Speciality Chemicals holds multiple ISO certifications including ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018, reflecting its commitment to quality, environmental, and occupational health and safety management systems.

This quarterly submission represents standard regulatory compliance for listed companies, ensuring transparency in securities handling and dematerialisation processes as mandated by SEBI regulations.

Privi Speciality Chemicals Limited has successfully completed a major capital expansion in its joint venture with Swiss fragrance giant Givaudan SA. The company announced on March 26, 2026, that both joint venture partners have subscribed to additional equity shares in Prigiv Specialties Private Limited, significantly strengthening the venture's financial foundation.

Capital Infusion Details

The Board of Directors of Prigiv Specialties Private Limited approved the circular resolution for equity share allotment on March 26, 2026. The preferential allotment was executed at ₹10 per equity share, with both partners making substantial investments to expand the joint venture's capital base.

Shareholding Structure Post-Allotment

Following the capital infusion, the ownership structure of Prigiv Specialties reflects the strategic partnership between the two companies. The expanded capital base demonstrates both partners' commitment to growing their collaborative venture.

Joint Venture Background

The capital subscription aligns with the Joint Venture Agreement originally entered into between Privi Speciality Chemicals Limited and Givaudan SA on July 29, 2021, along with subsequent Amendment Agreements. This structured approach ensures both parties maintain their strategic positions while providing necessary capital for business expansion.

Strategic Implications

The substantial capital increase from ₹35 crore to ₹85 crore represents a 142.86% growth in the joint venture's financial capacity. Privi Speciality Chemicals maintains its majority position with 51% ownership, while Givaudan SA holds a significant minority stake at 49%. This balanced partnership structure allows both companies to leverage their respective expertise in the specialty chemicals sector while maintaining strategic control proportionate to their investments.